Abstracts Archive - Page 795 of 1554 - MDS Abstracts

MDS Virtual Congress 2020
The ‘A’ in the A/T/N Alzheimer’s Disease Biomarker Classification Predicts Cognitive Outcomes in Parkinson’s Disease
N. Han, D. Weintraub, L. Shaw, J. Trojanowski, A. Chen-Plotkin, T. Tropea (Philadelphia, PA, USA)
Objective: To evaluate the Alzheimer’s disease (AD) A/T/N biomarker classification scheme as a predictor of longitudinal cognitive outcomes in Parkinson’s disease (PD). Background: Dementia is…
MDS Virtual Congress 2020
Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials
P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang (Guangzhou, China)
Objective: This study aimed to evaluate the effects of rTMS for improving cognition of PD patients. Background: Up to 20%–50% of patients with Parkinson’s disease…
MDS Virtual Congress 2020
Pareidolias and Cognition in Isolated REM Sleep Behavior Disorder
L. Honeycutt, J.F Gagnon, A. Pelletier, J. De Roy, J. Montplaisir, R. Postuma (Montreal, QC, Canada)
Objective: The objective of this study is to investigate the relationship between errors on the pareidolia test and global cognition in patients with REM sleep…
MDS Virtual Congress 2020
The effect of Deep Brain Stimulation in patients with Parkinson’s Disease on the Brain Cognitive Functions
A. Ivashynka, A. Cucovici (Novara, Italy)
Objective: To evaluate the effect of Deep Brain Stimulation (DBS) on cognitive functions and affective symptoms in patients with Parkinson's Disease (PD). Background: DBS helps…
MDS Virtual Congress 2020
Genetic and environmental prognostics of cognitive trajectories in patients with Parkinson’s disease
S. Jo, K.W Park, S.H Lee, Y.S Hwang, S.J Chung (Seoul, Republic of Korea)
Objective: We aimed to investigate the progression patterns of cognitive impairment in patients with Parkinson’s disease (PD), and to identify the baseline predictors, including both…
MDS Virtual Congress 2020
The relationship between REM sleep behavior disorder and cognitive impairment in drug-naïve Parkinson’s disease
A. Karukote, S. Thakolwiboon, P. Julayanont (Lubbock, TX, USA)
Objective: We aim to compare the cognitive performances of drug-naïve PD patients who had RBD (PD-RBD) to PD patients without RBD (PD-NRBD) and healthy controls.…
MDS Virtual Congress 2020
Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease
G. Kenangil, M. Demir, E. Tur, F. Domaç (Istanbul, Turkey)
Objective: The aim of our study is to examine the relation of alexithymia with cognition and depression in non-demented patients with Parkinson's disease (PD). Background:…
MDS Virtual Congress 2020
Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease
Y.S Kim, S.M Kim, H.W Shin, Y.C Youn, S.W Kang (Seoul, Republic of Korea)
Objective: We performed an exploratory analysis of the correlation of brain activity measured using qEEG and early cognitive function in patients with de novo PD.…
MDS Virtual Congress 2020
Baseline Predictors of Constipation and Probable Rapid Eye Movement Sleep Behavior Disorder (pRBD) for Cognitive Impairment After 5 Years of Parkinson’s Disease (PD) Diagnosis in the Parkinson’s Progression Markers Initiative Cohort (PPMI)
W.L Kong, Y. Huang, E. Qian, M. Morris (Sydney, Australia)
Objective: Cognitive impairment is linked to morbidity and mortality in patients with PD, this study aims to investigate whether the presence of constipation and RBD…
MDS Virtual Congress 2020
Behavioral and Psychological Symptoms in Patients with Movement Disorders
M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)
Objective: To find out the prevalence of neuropsychiatric symptoms in patients with Movement Disorders. To find out the relationship between cognitive impairment and neuropsychiatric symptoms…